149 related articles for article (PubMed ID: 17276034)
1. Ankyrin repeat and SOCS box containing protein 4 (Asb-4) interacts with GPS1 (CSN1) and inhibits c-Jun NH2-terminal kinase activity.
Li JY; Chai BX; Zhang W; Liu YQ; Ammori JB; Mulholland MW
Cell Signal; 2007 Jun; 19(6):1185-92. PubMed ID: 17276034
[TBL] [Abstract][Full Text] [Related]
2. Ankyrin repeat and SOCS box containing protein 4 (Asb-4) colocalizes with insulin receptor substrate 4 (IRS4) in the hypothalamic neurons and mediates IRS4 degradation.
Li JY; Chai B; Zhang W; Wu X; Zhang C; Fritze D; Xia Z; Patterson C; Mulholland MW
BMC Neurosci; 2011 Sep; 12():95. PubMed ID: 21955513
[TBL] [Abstract][Full Text] [Related]
3. Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II.
Chung AS; Guan YJ; Yuan ZL; Albina JE; Chin YE
Mol Cell Biol; 2005 Jun; 25(11):4716-26. PubMed ID: 15899873
[TBL] [Abstract][Full Text] [Related]
4. Arcuate nucleus transcriptome profiling identifies ankyrin repeat and suppressor of cytokine signalling box-containing protein 4 as a gene regulated by fasting in central nervous system feeding circuits.
Li JY; Kuick R; Thompson RC; Misek DE; Lai YM; Liu YQ; Chai BX; Hanash SM; Gantz I
J Neuroendocrinol; 2005 Jun; 17(6):394-404. PubMed ID: 15929745
[TBL] [Abstract][Full Text] [Related]
5. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling.
Sharfi H; Eldar-Finkelman H
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E307-15. PubMed ID: 18029441
[TBL] [Abstract][Full Text] [Related]
6. Ankyrin repeat and suppressors of cytokine signaling box protein asb-9 targets creatine kinase B for degradation.
Debrincat MA; Zhang JG; Willson TA; Silke J; Connolly LM; Simpson RJ; Alexander WS; Nicola NA; Kile BT; Hilton DJ
J Biol Chem; 2007 Feb; 282(7):4728-4737. PubMed ID: 17148442
[TBL] [Abstract][Full Text] [Related]
7. Asb6, an adipocyte-specific ankyrin and SOCS box protein, interacts with APS to enable recruitment of elongins B and C to the insulin receptor signaling complex.
Wilcox A; Katsanakis KD; Bheda F; Pillay TS
J Biol Chem; 2004 Sep; 279(37):38881-8. PubMed ID: 15231829
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes.
Gao Z; Zhang X; Zuberi A; Hwang D; Quon MJ; Lefevre M; Ye J
Mol Endocrinol; 2004 Aug; 18(8):2024-34. PubMed ID: 15143153
[TBL] [Abstract][Full Text] [Related]
9. ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexes.
Kohroki J; Nishiyama T; Nakamura T; Masuho Y
FEBS Lett; 2005 Dec; 579(30):6796-802. PubMed ID: 16325183
[TBL] [Abstract][Full Text] [Related]
10. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
McDaneld TG; Spurlock DM
J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
[TBL] [Abstract][Full Text] [Related]
11. Expression of testis specific ankyrin repeat and SOCS box-containing 17 gene.
Guo JH; Saiyin H; Wei YH; Chen S; Chen L; Bi G; Ma LJ; Zhou GJ; Huang CQ; Yu L; Dai L
Arch Androl; 2004; 50(3):155-61. PubMed ID: 15204681
[TBL] [Abstract][Full Text] [Related]
12. Expression of ankyrin repeat and suppressor of cytokine signaling box protein 4 (Asb-4) in proopiomelanocortin neurons of the arcuate nucleus of mice produces a hyperphagic, lean phenotype.
Li JY; Chai BX; Zhang W; Wang H; Mulholland MW
Endocrinology; 2010 Jan; 151(1):134-42. PubMed ID: 19934378
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of the genes encoding the ankyrin repeat and SOCS box-containing proteins Asb-1, Asb-2, Asb-3 and Asb-4.
Kile BT; Viney EM; Willson TA; Brodnicki TC; Cancilla MR; Herlihy AS; Croker BA; Baca M; Nicola NA; Hilton DJ; Alexander WS
Gene; 2000 Nov; 258(1-2):31-41. PubMed ID: 11111040
[TBL] [Abstract][Full Text] [Related]
14. [Exogenous expression of SOCS box-deficient mutant ASB-8 suppresses the growth of lung adenocarcinoma SPC-A1 cells].
Liu YZ; Li JJ; Zhang FR; Shen Y; Yao M; Wan DF; Gu JR
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jun; 35(6):548-53. PubMed ID: 12796816
[TBL] [Abstract][Full Text] [Related]
15. Insulin receptor and IRS-1 co-immunoprecipitation with SOCS-3, and IKKα/β phosphorylation are increased in obese Zucker rat skeletal muscle.
Zolotnik IA; Figueroa TY; Yaspelkis BB
Life Sci; 2012 Oct; 91(15-16):816-22. PubMed ID: 22982470
[TBL] [Abstract][Full Text] [Related]
16. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
[TBL] [Abstract][Full Text] [Related]
17. Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems.
Calegari VC; Alves M; Picardi PK; Inoue RY; Franchini KG; Saad MJ; Velloso LA
Endocrinology; 2005 Feb; 146(2):579-88. PubMed ID: 15514089
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and characterization of the human ASB-8 gene encoding a novel member of ankyrin repeat and SOCS box containing protein family.
Liu Y; Li J; Zhang F; Qin W; Yao G; He X; Xue P; Ge C; Wan D; Gu J
Biochem Biophys Res Commun; 2003 Jan; 300(4):972-9. PubMed ID: 12559969
[TBL] [Abstract][Full Text] [Related]
19. ASB4 is a hydroxylation substrate of FIH and promotes vascular differentiation via an oxygen-dependent mechanism.
Ferguson JE; Wu Y; Smith K; Charles P; Powers K; Wang H; Patterson C
Mol Cell Biol; 2007 Sep; 27(18):6407-19. PubMed ID: 17636018
[TBL] [Abstract][Full Text] [Related]
20. Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells.
Natalicchio A; De Stefano F; Orlando MR; Melchiorre M; Leonardini A; Cignarelli A; Labarbuta R; Marchetti P; Perrini S; Laviola L; Giorgino F
Endocrinology; 2010 May; 151(5):2019-29. PubMed ID: 20219981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
